“WHO and RDIF met at the end of November to discuss the need for more data on the quality, safety and efficacy of the vaccine.

The company has pledged to provide a detailed roadmap for data submission so that WHO can accelerate the evaluation of the vaccine, ”RIA Novosti reported.

WHO added that it expects data to be submitted by the end of December this year.

“You cannot expect an inspection before the data is presented and evaluated,” the organization concluded.

Earlier, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that WHO is delaying approval of the Sputnik V vaccine due to bureaucratic obstacles.